merican Thoracic Society (ATS) International Conference Archives

New Retrospective Data on African Americans with Advanced Symptomatic Sarcoidosis Treated with Acthar Gel Presented at the American Thoracic Society Annual International Conference

African-Americans, Business, Clinical Data, Clinical Trials, Mallinckrodt, merican Thoracic Society (ATS) International Conference, Sarcoidosis, Studies, Therapeutics

Global biopharmaceutical company Mallinckrodt plc announced results of a retrospective, observational medical chart review subgroup analysis assessing real-world treatment outcomes among African Americans with advanced symptomatic sarcoidosis who initiated therapy with Acthar Gel (repository corticotropin injection).

May 17, 2022/by PR Newswire

Boehringer Ingelheim Lands Positive Results in Lung Disease Trial

Clinical Trials, Connective Tissue, Data, European Medicines Agency, FDA, Idiopathic Pulmonary Fibrosis, merican Thoracic Society (ATS) International Conference, Priority Review Status, R&D, Researchers, Scleroderma, Systemic Sclerosis-Associated Interstitial Lung Disease (SSc-ILD), The New England Journal of Medicine (NEJM)

Boehringer Ingelheim’s SENSCIS Phase III clinical trial met the primary endpoint for nintedanib in patients with SSc-ILD.

May 21, 2019/by BioSpace